These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 25710585)

  • 61. [Clinico-pathological characteristics of colonic carcinoma in relation to localization and histologic type].
    Zivković V; Katić V; Dordević B; Krstić M; Pejović S; Petrović A
    Vojnosanit Pregl; 2007 Dec; 64(12):827-31. PubMed ID: 18357906
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [A case of multiple carcinomas in the same patient].
    Martínez Grau I; Alonso Santiago M; Cobo Rossell MR; Melgosa Moreno S
    Semergen; 2018 Oct; 44(7):510-512. PubMed ID: 30146119
    [No Abstract]   [Full Text] [Related]  

  • 63. Study on the clinical significance of Argonaute2 expression in colonic carcinoma by tissue microarray.
    Wang YX; Zhang XY; Zhang BF; Yang CQ; Gao HJ
    Int J Clin Exp Pathol; 2013; 6(3):476-84. PubMed ID: 23411422
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [HNPCC syndrome].
    Guimbaud R
    Gastroenterol Clin Biol; 2005 Oct; 29(10):1041-3. PubMed ID: 16435514
    [No Abstract]   [Full Text] [Related]  

  • 65. BRAF testing modalities in histiocytic disorders: Comparative analysis and proposed testing algorithm.
    Acosta-Medina AA; Abeykoon JP; Go RS; Goyal G; Ravindran A; Schram SM; Rech KL
    Am J Clin Pathol; 2023 Nov; 160(5):483-489. PubMed ID: 37458275
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Immunohistochemical Profile of Tumor Pathways and Prognostic Significance in Colon Adenocarcinomas.
    Senol S; Ceyran AB; Kösemetin D; Gobanoglu B; Aydin D; Duran EA; Leblebici M
    J Environ Pathol Toxicol Oncol; 2017; 36(1):29-41. PubMed ID: 28605329
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A novel low-grade nasopharyngeal adenocarcinoma characterized by a GOLGB1-BRAF fusion gene.
    Bubola J; Antonescu CR; Weinreb I; Swanson D; De Almeida JR; MacMillan CM; Dickson BC
    Genes Chromosomes Cancer; 2021 Jan; 60(1):49-53. PubMed ID: 32951290
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Correlation between high expression levels of jumonji domain-containing 4 and short survival in cases of colon adenocarcinoma.
    Ho YJ; Shih CP; Yeh KT; Shi B; Gong Z; Lin YM; Lu JW
    Biochem Biophys Res Commun; 2018 Sep; 503(3):1442-1449. PubMed ID: 30029884
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The Sensitivity and Specificity of Novel Primers for Detection of BRAFV600E Mutation.
    Tayeb BA; Pringle HJ
    Asian Pac J Cancer Prev; 2020 Nov; 21(11):3191-3198. PubMed ID: 33247675
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Ultrastructural markers of colonic adenocarcinoma.
    Hickey WF; Seiler MW
    Cancer; 1981 Jan; 47(1):140-5. PubMed ID: 7193076
    [TBL] [Abstract][Full Text] [Related]  

  • 71. BRAF mutation in colorectal carcinomas with signet ring cell component.
    Yalcin S; Onguru O
    Cancer Biol Med; 2017 Aug; 14(3):287-292. PubMed ID: 28884045
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Colorectal carcinoma with osseous metaplasia.
    Liu X; Xu J; Chen L
    Oncotarget; 2017 Sep; 8(39):65407-65413. PubMed ID: 29029440
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Unusual case of intussuscepting right colon cancer in a 21-year-old with Lynch syndrome.
    McLeod KG; Balasuriya HD; Hodder RJ
    ANZ J Surg; 2021 Jun; 91(6):E413-E414. PubMed ID: 33394557
    [No Abstract]   [Full Text] [Related]  

  • 74. Colorectal Adenocarcinoma in a 35-year-old Female with No Germline Mutations.
    van Oosbree A; Leigh L; Burt M; Garry R
    S D Med; 2023 Aug; 76(8):347-350. PubMed ID: 37734077
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Diagnosis for carcinoma of unknown primary site with the aid of simple PCR tests: a single-center experience.
    Suspitsin E; Yanus G; Imyanitov E
    Neoplasma; 2018 Mar; 65(3):461-468. PubMed ID: 29788737
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Automated objective determination of percentage of malignant nuclei for mutation testing.
    Viray H; Coulter M; Li K; Lane K; Madan A; Mitchell K; Schalper K; Hoyt C; Rimm DL
    Appl Immunohistochem Mol Morphol; 2014; 22(5):363-71. PubMed ID: 24162261
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Adenocarcinoma of the colon in an adolescent with the family cancer syndrome.
    Aiges HW; Kahn E; Silverberg M; Daum F
    J Pediatr; 1979 Apr; 94(4):632-3. PubMed ID: 430310
    [No Abstract]   [Full Text] [Related]  

  • 78. Expression of p-AMPK in colorectal cancer revealed substantial diverse survival patterns.
    Khabaz MN; Abdelrahman AS; Al-Maghrabi JA
    Pak J Med Sci; 2019; 35(3):685-690. PubMed ID: 31258576
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Atypical colonic stromal tumor].
    Miquel Plaza J; Martín De Argila C; Martínez Molina E; González-Palacios J; Sanjuán Benito A; Boixeda De Miquel D
    Gastroenterol Hepatol; 2001; 24(7):339-42. PubMed ID: 11481068
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Science to practice: Son et Lumiere--understanding tumor heterogeneity.
    Mezrich R
    Radiology; 2012 May; 263(2):313-5. PubMed ID: 22517950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.